Jennifer Bordeaux
Jennifer Bordeaux
Yale University
Verified email at genoptix.com
Title
Cited by
Cited by
Year
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
5972010
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
5972010
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis
V Neumeister, S Agarwal, J Bordeaux, RL Camp, DL Rimm
The American journal of pathology 176 (5), 2131-2138, 2010
1622010
Lin28 regulates HER2 and promotes malignancy through multiple mechanisms
C Feng, V Neumeister, W Ma, J Xu, L Lu, J Bordeaux, NJ Maihle, ...
Cell cycle 11 (13), 2486-2494, 2012
702012
Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen
JM Bordeaux, H Cheng, AW Welsh, BG Haffty, DR Lannin, X Wu, N Su, ...
PloS one 7 (5), e36559, 2012
592012
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti–PD-1 therapies in metastatic melanoma
DB Johnson, J Bordeaux, JY Kim, C Vaupel, DL Rimm, TH Ho, ...
Clinical Cancer Research 24 (21), 5250-5260, 2018
572018
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
DB Johnson, MJ Nixon, Y Wang, DY Wang, E Castellanos, MV Estrada, ...
JCI insight 3 (24), 2018
522018
Bulk bag for meat and meat products
JR Richardson Jr, BM Eisenbarth, BG Brown
US Patent 6,739,753, 2004
452004
Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling
PJ Siska, RAN Johnpulle, A Zhou, J Bordeaux, JY Kim, B Dabbas, ...
Oncoimmunology 6 (4), e1305535, 2017
342017
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
KE Beckermann, PC Jolly, JY Kim, J Bordeaux, I Puzanov, WK Rathmell, ...
Journal for immunotherapy of cancer 5 (1), 1-5, 2017
302017
The function, proteolytic processing, and histopathology of Met in cancer
JA Hanna, J Bordeaux, DL Rimm, S Agarwal
Advances in cancer research 103, 1-23, 2009
292009
Influence of tumor microenvironment on prognosis in colorectal cancer: tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
DJ O'Shannessy, EB Somers, LK Chandrasekaran, NC Nicolaides, ...
Oncotarget 5 (12), 3983, 2014
272014
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
H Bitter, JM Bordeaux, B Brannetti, J Brogdon, NK Dakappagari, S Gill, ...
US Patent 10,253,086, 2019
262019
In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients
M Vassilakopoulou, T Togun, U Dafni, H Cheng, J Bordeaux, ...
PLoS One 9 (6), e99131, 2014
212014
Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections
S Rost, J Giltnane, JM Bordeaux, C Hitzman, H Koeppen, SD Liu
Laboratory Investigation 97 (8), 992-1003, 2017
18*2017
Improved prognosis and increased tumor-infiltrating lymphocytes in patients who have SCLC with neurologic paraneoplastic syndromes
WT Iams, E Shiuan, CB Meador, M Roth, J Bordeaux, C Vaupel, KL Boyd, ...
Journal of Thoracic Oncology 14 (11), 1970-1981, 2019
152019
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method
Y Bai, H Cheng, J Bordeaux, V Neumeister, S Kumar, DL Rimm, DF Stern
PLoS One 8 (11), e79901, 2013
132013
Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)-expressing cell
H Bitter, JM Bordeaux, B Brannetti, J Brogdon, NK Dakappagari, S Gill, ...
US Patent App. 16/256,731, 2019
52019
MHC-II expression to drive a unique pattern of adaptive resistance to antitumor immunity through receptor checkpoint engagement.
JM Balko, DB Johnson, DY Wang, P Ericsson-Gonzalez, M Nixon, ...
Journal of Clinical Oncology 36 (5_suppl), 180-180, 2018
52018
novel quantitative multiplexed PD-1/PD-L1 immunohistochemistry test provides superior prediction of treatment response in melanoma patients
J Bordeaux, D Johnson, J Sosman, JY Kim, C Vaupel, B Dabbas, J Cates, ...
Cancer Research 76 (14 Supplement), 853-853, 2016
42016
The system can't perform the operation now. Try again later.
Articles 1–20